课题基金 / 基金详情

Degradable nanocapsules for thromboprophylaxis and treatment of acute thrombosis

Degradable nanocapsules for thromboprophylaxis and treatment of acute thrombosis
可降解纳米胶囊用于血栓预防和治疗急性血栓形成
批准号:
nhmrc : 1138361
负责人:
A/Pr Christoph Hagemeyer
金额:
$78.33万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 2021-12-31

项目摘要

项目成果

A/Pr Christoph Hagemeyer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The consequences of fat build up in vessels such as heart attacks and brain infarcts are the major cause of death in Australia. Clot busters have been proven to be beneficial for patients with heart attacks, clots in the legs or lungs and brain infarcts. However, the currently available drugs have major limitations in efficacy and in safety. The aim of this project is to develop novel drugs that have the potential to improve both significantly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Smart targeted nanoparticles for diagnosis and therapy
  • 批准号:
    nhmrc : GNT1154270
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $72.42万
  • 财政年份:
    2019
  • 负责人:
    A/Pr Christoph Hagemeyer
  • 依托单位:
Degradable nanocapsules for thromboprophylaxis and treatment of acute thrombosis
  • 批准号:
    nhmrc : GNT1138361
  • 项目类别:
    Project Grants
  • 资助金额:
    $115.84万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christoph Hagemeyer
  • 依托单位:
Molecular imaging and therapy of cardiac fibrosis in atrial fibrillation and heart failure
  • 批准号:
    nhmrc : 1120129
  • 项目类别:
    Project Grants
  • 资助金额:
    $68.96万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Christoph Hagemeyer
  • 依托单位:
Molecular imaging and therapy of cardiac fibrosis in atrial fibrillation and heart failure
  • 批准号:
    nhmrc : GNT1120129
  • 项目类别:
    Project Grants
  • 资助金额:
    $102.17万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Christoph Hagemeyer
  • 依托单位:
海外基金